During the past decade, SCRI The Center For Cancer and Blood Disorders conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SCRI The Center For Cancer and Blood Disorders" are "Carcinoma, Non-Squamous Non-Small Cell Lung" (1 trials) and "Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "SCRI The Center For Cancer and Blood Disorders" in a lesser frequency.

Most popular intervention types in "SCRI The Center For Cancer and Blood Disorders" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Nab-Paclitaxel" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "SCRI The Center For Cancer and Blood Disorders" are 2 trials for "All" genders.

Currently, there are NaN active trials in "SCRI The Center For Cancer and Blood Disorders". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in SCRI The Center For Cancer and Blood Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SCRI The Center For Cancer and Blood Disorders, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".